Phenylketonuria history and symptoms: Difference between revisions
Jump to navigation
Jump to search
YazanDaaboul (talk | contribs) No edit summary |
m (Categories) |
||
| (2 intermediate revisions by one other user not shown) | |||
| Line 2: | Line 2: | ||
{{Phenylketonuria}} | {{Phenylketonuria}} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}} | ||
==Overview== | ==Overview== | ||
==History and Symptoms== | ==History and Symptoms== | ||
'''Maternal PKU''' | |||
Clinical manifestations in the newborn:<ref name="pmid25712380">{{cite journal| author=Waisbren SE, Rohr F, Anastasoaie V, Brown M, Harris D, Ozonoff A et al.| title=Maternal Phenylketonuria: Long-term Outcomes in Offspring and Post-pregnancy Maternal Characteristics. | journal=JIMD Rep | year= 2015 | volume= | issue= | pages= | pmid=25712380 | doi=10.1007/8904_2014_365 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25712380 }} </ref><ref name="pmid19485248">{{cite journal| author=Didycz B, Domagała L, Pietrzyk JJ| title=[The maternal phenylketonuria syndrom--still current problem]. | journal=Przegl Lek | year= 2009 | volume= 66 | issue= 1-2 | pages= 4-10 | pmid=19485248 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19485248 }} </ref> | |||
* Low weight at birth. | |||
* Microcephaly. | |||
* Intellectual disabilities. | |||
* Congenital heart disease (especially of left heart chambers). | |||
* Digestive tract deffects. | |||
* Renal malformations. | |||
Clinical manifestations in the mother: | |||
* Multiple abortions. | |||
The fetus starts producing PAH hepatic enzyme by the 26<sup>th</sup>week of pregnancy, before this, the fetus depends on the mother to metabolize the Phe, and if she has a deficiency of PAH, the fetus will double the Phe blood levels of the mother, which is why women with PKU should follow strict diet and treatment before, and during the pregnancy. | |||
* Ideal levels of Phe during pregnancy: <180 µmol/L | |||
* Teratogenic and neurotoxic levels of Phe: 360 µmol/L | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Pediatrics]] | [[Category:Pediatrics]] | ||
[[Category:Neurology]] | [[Category:Neurology]] | ||
[[Category: | [[Category:Endocrinology]] | ||
{{WS}} | |||
{{WH}} | |||
Latest revision as of 13:12, 26 July 2016
|
Phenylketonuria Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Phenylketonuria On the Web |
|
American Roentgen Ray Society Images of Phenylketonuria |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
History and Symptoms
Maternal PKU
Clinical manifestations in the newborn:[1][2]
- Low weight at birth.
- Microcephaly.
- Intellectual disabilities.
- Congenital heart disease (especially of left heart chambers).
- Digestive tract deffects.
- Renal malformations.
Clinical manifestations in the mother:
- Multiple abortions.
The fetus starts producing PAH hepatic enzyme by the 26thweek of pregnancy, before this, the fetus depends on the mother to metabolize the Phe, and if she has a deficiency of PAH, the fetus will double the Phe blood levels of the mother, which is why women with PKU should follow strict diet and treatment before, and during the pregnancy.
- Ideal levels of Phe during pregnancy: <180 µmol/L
- Teratogenic and neurotoxic levels of Phe: 360 µmol/L
References
- ↑ Waisbren SE, Rohr F, Anastasoaie V, Brown M, Harris D, Ozonoff A; et al. (2015). "Maternal Phenylketonuria: Long-term Outcomes in Offspring and Post-pregnancy Maternal Characteristics". JIMD Rep. doi:10.1007/8904_2014_365. PMID 25712380.
- ↑ Didycz B, Domagała L, Pietrzyk JJ (2009). "[The maternal phenylketonuria syndrom--still current problem]". Przegl Lek. 66 (1–2): 4–10. PMID 19485248.